Ardelyx reported $102.27M in Selling and Administration Expenses for its fiscal quarter ending in March of 2026.





Selling And Administration Expenses Change Date
Abbott USD 3.27B 138M Mar/2026
Amgen USD 1.58B 354M Mar/2026
Ardelyx USD 102.27M 26.35M Mar/2026
aTyr Pharma USD 700.63K 81.56M Mar/2026
Corcept Therapeutics USD 128.04M 13.3M Mar/2026
Curis USD 1.34M 3.45M Dec/2025
Sanofi EUR 2.49B 252M Mar/2026
TG Therapeutics USD 73.14M 22.42M Mar/2026
United Therapeutics USD 156.6M 34M Mar/2026
Xoma USD 11M 2.54M Jun/2024